{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:14:29Z","timestamp":1780992869009,"version":"3.54.1"},"reference-count":0,"publisher":"Medical Education Cooperation with Cuba","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.37757\/mr2011v13.n1.9","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T05:20:56Z","timestamp":1593062456000},"page":"35","source":"Crossref","is-referenced-by-count":4,"title":["Introduction of Imatinib as First-line Therapy for Chronic Myeloid Leukemia in Cuba"],"prefix":"10.37757","volume":"13","member":"23840","container-title":["MEDICC Review"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T05:21:05Z","timestamp":1593062465000},"score":1,"resource":{"primary":{"URL":"http:\/\/mediccreview.org\/introduction-of-imatinib-as-first-line-therapy-for-chronic-myeloid-leukemia-in-cuba\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.37757\/mr2011v13.n1.9","relation":{},"ISSN":["1555-7960"],"issn-type":[{"value":"1555-7960","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}